Natasha Jolakoski: Completing Advanced Training in Thrombosis and Hemostasis
Natasha Jolakoski, Clinical Pharmacy Specialist in Thrombosis and Hemostasis Management, shared a post on LinkedIn:
“I am excited to announce the completion of my PGY2 Residency in Thrombosis and Hemostasis Management at the University of New Mexico Hospital!
I am incredibly grateful to my preceptors, co-residents, colleagues, friends, and family for their guidance, encouragement, and unwavering support throughout this journey.
I truly would not be where I am today without each of you.
I am also excited to share that I will be joining UT Southwestern Medical Center as a Clinical Pharmacy Specialist in Thrombosis and Hemostasis Management. I look forward to this next chapter, continuing to grow as a clinician and embracing my role as a Thrombassador.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE
-
Oct 12, 2026, 20:43Jazlyn A Selvasingh: Excited to Share Our Research at AAO-HNSF 2026 in Los Angeles
-
Oct 12, 2026, 20:31Natalia Kovtun: Higher Ferritin Cutoffs Now Define Iron Deficiency
-
Oct 12, 2026, 19:39Edward Loftus: Using Low-Dose Aspirin in Pregnant Women With IBD
-
Oct 12, 2026, 19:32Shruti Sachdeva: Strengthening the Fight against Anemia